BlackBerry and NantHealth Monday announced a new way for doctors to access and share information on cancer patients.
According to a press release the companies are launching a secure clinical genome browser that will allow doctors access to patients’ genetic data on the BlackBerry Passport smartphone, using the the NantOmics Cancer Genome Browser.
Using the platform, doctors will be able to better understand what makes one patient’s cancer different from another, while also accessing the best treatment options for that type of cancer.
BlackBerry CEO John Chen said in a statement that the partnership with NantHealth illustrates how his company’s technology can be used to facilitate collaboration across industries.
“BlackBerry technology has proven itself secure, reliable and powerful enough to be counted on in life-and-death situations,” Chen said. “Its innovative form and functionality make BlackBerry Passport an ideal addition to a doctor’s medical kit.”
The NantOmics Cancer Genome Browser is fully encrypted and HIPPA certified.
The two companies will be demonstrating the genome browser at the Consumer Electronics Show (CES) in January and will be preloaded on some BlackBerry Passport devices and available to the professional community in early 2015.